ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00116389
Recruitment Status : Terminated (FDA Hold May 2007)
First Posted : June 29, 2005
Last Update Posted : June 8, 2007
Sponsor:
Information provided by:
Point Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : No date given